Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. — CFSMEATLAS
Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Schreiner, Philipp, Harrer, Thomas, Scheibenbogen, Carmen et al. · ImmunoHorizons · 2020 · DOI
Quick Summary
This study explores how a virus called HHV-6 might trigger ME/CFS by examining what happens inside cells when the virus reactivates. The researchers found that when HHV-6 wakes up, it causes cells to switch into a protective mode that fights other viruses but seriously damages the cell's power plants (mitochondria) and energy-making abilities. Importantly, blood serum from ME/CFS patients showed similar patterns, suggesting HHV-6 reactivation may play a role in the disease.
Why It Matters
This research provides a potential mechanistic link between HHV-6 reactivation and ME/CFS pathology, specifically explaining how the infection might trigger the characteristic combination of antiviral activation and energy metabolism failure seen in patients. Understanding this mechanism could lead to targeted therapeutic interventions and better diagnostic approaches for ME/CFS.
Observed Findings
HHV-6 reactivation induced mitochondrial fragmentation and suppressed key energy metabolism enzymes including pyruvate dehydrogenase and superoxide dismutase 2.
Supernatants from reactivated HHV-6 cells conferred antiviral protection against influenza-A and HSV-1 in naive cells.
Blood serum from 10 ME/CFS patients reproduced both the mitochondrial fragmentation pattern and antiviral state in cell assays.
Inferred Conclusions
HHV-6 reactivation activates a cell danger response that prioritizes antiviral defense at the expense of energy metabolism and mitochondrial function.
The mitochondrial fragmentation and metabolic suppression pattern seen in ME/CFS patient serum suggests HHV-6 reactivation may be involved in ME/CFS pathogenesis.
HHV-6-induced metabolic changes create a trade-off: protection against viral superinfection but severe compromise of cellular energy production.
Remaining Questions
Does HHV-6 reactivation directly cause ME/CFS, or does it trigger the condition only in genetically or immunologically susceptible individuals?
What other factors or co-triggers might be necessary alongside HHV-6 reactivation to produce the full ME/CFS clinical syndrome?
What This Study Does Not Prove
This study does not prove that HHV-6 reactivation causes ME/CFS in all patients, as correlation and laboratory findings do not establish causation in the complex multifactorial disease. The work does not explain why some individuals with HHV-6 reactivation develop ME/CFS while others do not, nor does it exclude other triggers. Additionally, cell culture findings may not fully translate to the complex human immune and metabolic environment.